Takotsubo Syndrome (TTS) is a condition of transient left ventricular dysfunction that is typically triggered by emotional or physical stress. Since first described in Japan in 1990, it has increasingly been recognised in clinical practice, accounting for up to 2% of Acute Coronary Syndrome (ACS) presentations. In fact, the clinical presentation can be indistinguishable from a myocardial infarction. Although current evidence suggests a catecholamine induced myocardial stunning, the pathophysiological mechanisms remain unknown. Interestingly, it is more common in woman, particularly those who are post-menopausal. This review aims to summarise the current research and provide an overview of the diagnostic strategies and treatment options.
Worsening heart failure is often preceded by days-to-weeks of physiological deterioration; yet, remote-monitoring alerts are clinician-facing and may not translate into timely action. The authors evaluated a patient-facing HeartLogic-guided Mobile Health (mHealth) pathway designed to augment usual care. The purpose of this study was to assess feasibility, acceptability, and exploratory clinical associations of a patient-facing HeartLogic-triggered early-warning pathway. This single-center, pragmatic, randomized pilot trial recruited adults with heart failure and a HeartLogic-capable implantable cardioverter-defibrillator, randomized 1:1 to usual care or usual care plus weekly patient-facing HeartLogic-triggered notifications via an mHealth platform with symptom screening and self-care guidance. Coprimary outcomes were feasibility/acceptability and HeartLogic recovery metrics. Follow-up ranged from 12 to 24 months. A total of 160 participants were randomized (81 intervention, 79 control); median follow-up was 1.82 years. Recruitment reached 160 of 200 participants (80% of target), retention was high, and mean Mobile App Usability Questionnaire scores demonstrated acceptability throughout follow-up. Engagement was high with 80% symptom-screen completion during alerts. Compared with usual care, the intervention was associated with lower HeartLogic alert incidence (IRR: 0.78 [95% CI: 0.62-0.99]) and 13% more monitored days outside alert state (RR: 1.13 [95% CI: 1.02-1.25]), whereas time to alert normalization was similar. The traffic-light pathway supported risk-tiered patient response, with greater self-reported health care contact following red than amber alerts. Exploratory clinical outcomes were directionally favorable, but the study was not powered for these endpoints. In this randomized pilot trial, a patient-facing HeartLogic-guided mHealth pathway was feasible, acceptable, and associated with lower alert burden, supporting evaluation in a larger multicenter trial.
With this paper we communicated the existence of a surface electrocardiography (ECG) recordings dataset, named WCTECGdb, that aside from the standard 12-lead signals includes the raw electrode biopotential for each of the nine exploring electrodes refereed directly to the right leg. This dataset, comprises of 540 ten second segments recorded from 92 patients at Campbelltown Hospital, NSW Australia, and is now available for download from the Physionet platform. The data included in the dataset confirm that the Wilson’s Central Terminal (WCT) has a relatively large amplitude (up to 247% of lead II) with standard ECG characteristics such as a p-wave and a t-wave, and is highly variable during the cardiac cycle. As further examples of application for our data, we assess: (1) the presence of a conductive pathway between the legs and the heart concluding that in some cases is electrically significant and (2) the initial assumption about the limbs potential stating the dominance of the left arm concluding that this is not always the case and that might requires case to case assessment.
Background: Pocket haematomas are one of the most common complications post cardiovascular implantable electronic device (CIED) implantation. Objective: We explored the use of mechanical compression devices compared to the conventional dressings post CIED implantation, to reduce the incidence of pocket haematomas. Secondary outcomes were pain scores and wound scar or healing. Methods: Five electronic databases were systematically searched from their inception to 1st November 2023, identifying all studies which explored compression dressings post CIED implantation. Data were independently extracted by investigators according to predefined clinical endpoints. We used a Random-effects model for data analysis based on event rates (ER) and 95% confidence interval (CI). Results: Six studies (786 patients) were included in the meta-analysis, with 373 in the compression arm and 385 patients in the control groups across the studies. There was a total incidence of 82 haematomas, of which 24.4% were in the mechanical compression group and 75.6% in the conventional dressings group (RR 0.36, 95% CI 0.23- 0.57). One study suggested improved wound healing with the compression dressing arm (Manchester Scar Scale 9.5 at 2 weeks for the control group and 7.5 for the compression dressings group). Two studies suggested increased pain scores (using a visual analogue scale) shortly after dressing application. One study suggested improved comfort scores in the compression group compared to the control at 48 hours and 7 days. Conclusion: This systematic review and meta-analysis suggests for patients post CIED implantation, the use of novel mechanical compression dressings, when compared to conventional dressings, reduces the risk of pocket haematoma.Forest plot
8 August 2026 in Journal of Cardiac Failure - Intersections